Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapartum Papaverine for Perineal Trauma in Primiparous Women
NCT07641543Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Jun 2027
01
Overview
Randomised, double-blind trial in Perineal trauma and obstetric anal sphincter injury (OASI) comparing Papaverine Group with Placebo Group (2 arms). Primary endpoint: Rate of Perineal Trauma Requiring Suturing at 1 day. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
papaverine
03
Conditions
Perineal traumaobstetric anal sphincter injury (OASI)
Beyond the preview
Go deeper on NCT07641543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07641543.